Related Experiment Video
Updated: Jul 3, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness
1Department of Pain Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, PL 31-343 Kraków, Poland. joamika@if-pan.krakow.pl
Abstract:
Microglia play a crucial role in the maintenance of neuronal homeostasis in the central nervous system, and microglia production of immune factors is believed to play an important role in nociceptive transmission. There is increasing evidence that uncontrolled activation of microglial cells under neuropathic pain conditions induces the release of proinflammatory cytokines (interleukin - IL-1beta, IL-6, tumor necrosis factor - TNF-alpha), complement components (C1q, C3, C4, C5, C5a) and other substances that facilitate pain transmission. Additionally, microglia activation can lead to altered activity of opioid systems and neuropathic pain is characterized by resistance to morphine. Pharmacological attenuation of glial activation represents a novel approach for controlling neuropathic pain. It has been found that propentofylline, pentoxifylline, fluorocitrate and minocycline decrease microglial activation and inhibit proinflammatory cytokines, thereby suppressing the development of neuropathic pain. The results of many studies support the idea that modulation of glial and neuroimmune activation may be a potential therapeutic mechanism for enhancement of morphine analgesia. Researchers and pharmacological companies have embarked on a new approach to the control of microglial activity, which is to search for substances that activate anti-inflammatory cytokines like IL-10. IL-10 is very interesting since it reduces allodynia and hyperalgesia by suppressing the production and activity of TNF-alpha, IL-1beta and IL-6. Some glial inhibitors, which are safe and clinically well tolerated, are potential useful agents for treatment of neuropathic pain and for the prevention of tolerance to morphine analgesia. Targeting glial activation is a clinically promising method for treatment of neuropathic pain.
Insights
Targeting microglial activation offers a promising strategy for managing neuropathic pain and opioid tolerance. Inhibiting glial cells reduces pain signaling and enhances morphine
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Microglia are key to central nervous system homeostasis.
- Microglial activation releases pro-inflammatory cytokines (e.g., IL-1beta, IL-6, TNF-alpha) contributing to neuropathic pain.
- Neuropathic pain is often linked to morphine resistance due to altered opioid system activity.
Purpose of the Study:
- To explore the role of microglial activation in neuropathic pain.
- To investigate pharmacological approaches targeting glial activation for pain management.
- To assess the potential of modulating glial activity for enhancing opioid analgesia.
Main Methods:
- Review of studies on microglial activation in neuropathic pain models.
- Analysis of the effects of glial inhibitors (propentofylline, pentoxifylline, fluorocitrate, minocycline) on pain.
- Examination of the impact of anti-inflammatory cytokines (e.g., IL-10) on pain and opioid response.
Main Results:
- Uncontrolled microglial activation exacerbates neuropathic pain via pro-inflammatory mediators.
- Glial inhibitors effectively suppress microglial activation and reduce pain.
- Modulating glial activity shows potential for improving morphine analgesia and preventing tolerance.
Conclusions:
- Targeting glial activation is a viable therapeutic strategy for neuropathic pain.
- Glial inhibitors represent a novel approach for pain treatment and managing opioid tolerance.
- Further research into substances activating anti-inflammatory cytokines like IL-10 is warranted for pain management.
Related Concept Videos
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Nociception
Opioid Analgesics: Morphine and Other Natural Cogeners
